Antimicrobials used against uropathogens causing Urinary Tract Infection (UTI) and also to study the drug resistance(capacity of disease causing micro-organisms to withstand exposure to drugs) and sensitivity patterns.

Not yet recruiting

• Conditions: Urinary tract infection, site notspecified,

• Registration Number: CTRI/2019/12/022486

Brief Summary

Urinary Tract Infection (UTI) is a common bacterialinfection, which contributes to a frequent cause of morbidity in out-patientsas well as in hospitalized patients. There are numerous cases ofantimicrobial resistance to the commonly used antibiotics in the developed anddeveloping countries. Resistance to newer and more potent antimicrobialsare no exceptions, thereby making the therapeutic options very limited tocertain antimicrobial agents like carbapenem, colistin and fosfomycin. The updated knowledge and situation of the prevailing bacterial uropathogens thatare multidrug resistant (MDR) is of prime importance for the proper use ofantimicrobial drugs and also for policy making to combat multidrug resistancein UTIs. Antimicrobial resistance surveillance is necessary todetermine the size of the problem and to guide the empirical selection ofantimicrobial agents for treating infected patients. This study is aimed tostudy the profile of MDR uropathogens causing UTI in a tertiary care hospitaland assess their antimicrobial susceptibility pattern, clinical course andoutcome.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2019-12-18
• Study Start: 2019-12-23

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 1500

Inclusion Criteria

1.Subjects whose urine sample when processed showed significant growth of one or more organisms.

Exclusion Criteria

• 1.Subjects whose urine sample was contaminated.
• 3.Subjects whose urine sample showed insignificant bacteriuria.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. MDR Uropathogens causing UTI	6 months

Secondary Outcome Measures

Name	Time	Method
1. Antimicrobial susceptibility pattern	2. Clinical course and outcome

Trial Locations

Locations (1)

Kempegowda Institute of Medical Sciences Hospital and Research Centre, V V Puram, Bangalore 560004; 🇮🇳 Bangalore, KARNATAKA, India

Kempegowda Institute of Medical Sciences Hospital and Research Centre, V V Puram, Bangalore 560004

🇮🇳Bangalore, KARNATAKA, India

Dr R Abisha Rezia

Principal investigator

9486533058

abisharezia@gmail.com